Evaluation of neurological changes in secondary progressive multiple sclerosis patients treated with immune modulator MIS416: results from a feasibility study
Crossref DOI link: https://doi.org/10.1186/s40814-017-0201-4
Published Online: 2017-11-16
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Webster, Gill A.
Sim, Dalice A.
La Flamme, Anne C.
Mayo, Nancy E.